1. Home
  2. RCUS vs OPCH Comparison

RCUS vs OPCH Comparison

Compare RCUS & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$28.85

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Option Care Health Inc.

OPCH

Option Care Health Inc.

HOLD

Current Price

$21.96

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
OPCH
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.5B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
RCUS
OPCH
Price
$28.85
$21.96
Analyst Decision
Buy
Buy
Analyst Count
10
7
Target Price
$31.90
$36.57
AVG Volume (30 Days)
1.3M
2.6M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.25
EPS
N/A
0.29
Revenue
$247,000,000.00
$4,998,202,000.00
Revenue This Year
N/A
$7.21
Revenue Next Year
$45.62
$8.55
P/E Ratio
N/A
$75.90
Revenue Growth
N/A
16.17
52 Week Low
$7.92
$18.01
52 Week High
$29.85
$36.80

Technical Indicators

Market Signals
Indicator
RCUS
OPCH
Relative Strength Index (RSI) 69.69 52.99
Support Level $19.78 $19.61
Resistance Level N/A $22.25
Average True Range (ATR) 1.52 0.70
MACD 0.57 0.27
Stochastic Oscillator 88.14 75.87

Price Performance

Historical Comparison
RCUS
OPCH

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

About OPCH Option Care Health Inc.

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.

Share on Social Networks: